Risk factors for venous thromboembolism during pregnancy

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 12, 2013, Pages 1283-1291

  Jensen, Thomas Bo ^a   Gerds, Thomas Alexander ^b   Grøn, Randi ^b   Bretler, Ditte Marie ^a   Schmiegelow, Michelle Dalgas ^a   Andersson, Charlotte ^a   Azimi, Aziza ^a   Gislason, Gunnar ^a   Torp Pedersen, Christian ^a   Olesen, Jonas Bjerring ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Obesity; Pharmacoepidemiology; Pregnancy; Risk factors; Venous thromboembolism

Indexed keywords

AMIDE; AMINOSALICYLIC ACID; ANESTHETIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DIURETIC AGENT; ESTROGEN; ESTROGEN DERIVATIVE; HEPARIN; HEPARINOID; IMIDAZOLE DERIVATIVE; INSULIN; INSULIN DERIVATIVE; LIPID; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE DERIVATIVE; PARAFFIN; PENICILLIN DERIVATIVE; POTASSIUM SPARING DIURETIC AGENT; PROTON PUMP INHIBITOR; TOPICAL AGENT; VITAMIN B COMPLEX; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; DENMARK; FEMALE; GROUPS BY AGE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MATERNAL OBESITY; MATERNAL SMOKING; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

OBESITY; PHARMACOEPIDEMIOLOGY; PREGNANCY; RISK FACTORS; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGE FACTORS; COMORBIDITY; DENMARK; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MIDDLE AGED; OBESITY; PHARMACOEPIDEMIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SMOKING; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84888429355     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3536     Document Type: Article

References (28)

1. Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol 2010; 56(1): 1-7.
2. Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med 2008; 359(19): 2025-2033.
3. Schmidt M, Horvath-Puho E, Thomsen RW, Smeeth L, Sørensen HT. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. J Thromb Haemost 2011; 9(7): 1326-1333.
4. Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ 2010; 341: c4245.
5. Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009; 339: b2890.
6. Bjørn AM, Nørgaard M, Hundborg HH, Nohr EA, Ehrenstein V. Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark. Clin Epidemiol 2011; 3: 149-156.
7. Grzeskowiak LE, Gilbert AL, Morrison JL. Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy. Eur J Clin Pharmacol 2012; 68(5): 459-467.
8. Karasoy D, Jensen TB, Hansen ML, et al. Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study. Europace 2013; 15(6): 781-786.
9. Holm S. A Simple Sequentially Rejective Multiple Test Procedure. Scand J Stat 1979; 6(2): 65-70.
10. James A, B.-O. Committee on Practice. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol 2011; 118(3): 718-729.
11. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006; 194(5): 1311-1315.
12. Sultan AA, West J, Tata LJ, Fleming KM, Nelson-Piercy C, Grainge MJ. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. Br J Haematol 2012; 156(3): 366-373.
13. Lindqvist P, Dahlbäck B, Marŝál K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999; 94: 595-599.
14. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117(1): 93-102.
15. Larsen TB, Sørensen HT, Gislum M, Johnsen SP. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study. Thromb Res 2007; 120(4): 505-509.
16. Delluc A, Mottier D, Le Gal G, Oger E, Lacut K. Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study. J Thromb Haemost 2009; 7(4): 728-729.
17. Danilenko-Dixon DR, Heit JA, Silverstein MD, et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol 2001; 184(2): 104-110.
18. Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost 2008; 6(6): 905-912.
19. Olesen C, Søndergaard C, Thrane N, et al. Do pregnant women report use of dispensed medications? Epidemiology (Cambridge, Mass.) 2001; 12(5): 497-501.
20. Schmidt M, Horvath-Puho E, Thomsen RW, Smeeth L, Sørensen HT. Acute infections and venous thromboembolism. J Intern Med 2012; 271(6): 608-618.
21. Ahlehoff O, Gislason GH, Lindhardsen J, et al. Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study. PLoS One 2011; 6(3): e18125.
22. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010; 375(9715): 657-663.
23. Gee J, Naleway A, Shui I, et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine 2011; 29(46): 8279-8284.
24. Majoor CJ, Kamphuisen PW, Zwinderman AH, et al. Risk of deep-vein thrombosis and pulmonary embolism in asthma. Eur Respir J 2012.
25. Jönsson AK, Horváth-Puhó E, Hägg S, Pedersen L, Sørensen HT. Antipsychotics and risk of venous thromboembolism: A population-based case-control study. Clin Epidemiol 2009; 1: 19-26.
26. Hagg S, Jonsson AK, Spigset O. Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opin Drug Saf 2009; 8(5): 537-547.
27. Larsen TB, Johnsen SP, Møller CI, Larsen H, Sørensen HT. A review of medical records and discharge summary data found moderate to high predictive values of discharge diagnoses of venous thromboembolism during pregnancy and postpartum. J Clin Epidemiol 2005; 58(3): 316-319.
28. Bødker B, Hvidman L, Weber T, et al. Maternal deaths in Denmark 2002-2006. Acta Obstet Gynecol Scand 2009; 88: 556-562.